MURA
Price:
$2.04
Market Cap:
$35.38M
Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. The company was incorporated in 2017 and is based in Dublin, Ireland. As of November 15, 2023, Mural Oncology Plc operates as a former subsidiary of Alkermes plc.
Industry
Biotechnology
IPO Date
2023-11-16
Stock Exchange
NASDAQ
Ticker
MURA
According to Mural Oncology plc’s latest financial reports and current stock price. The company's current ROE is -122.29%. This represents a change of 215.65% compared to the average of -38.74% of the last 4 quarters.
The mean historical ROE of Mural Oncology plc over the last ten years is 433.70%. The current -122.29% ROE has changed -128.20% with respect to the historical average. Over the past ten years (40 quarters), MURA's ROE was at its highest in in the September 2023 quarter at 744.04%. The ROE was at its lowest in in the June 2025 quarter at -81.63%.
Average
433.70%
Median
422.52%
Minimum
-91.47%
Maximum
981.22%
Discovering the peaks and valleys of Mural Oncology plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 16.32%
Maximum Annual ROE = 981.22%
Minimum Annual Increase = -108.51%
Minimum Annual ROE = -91.47%
| Year | ROE | Change |
|---|---|---|
| 2024 | -91.47% | 16.32% |
| 2023 | -78.63% | -108.51% |
| 2022 | 923.67% | -5.87% |
The current ROE of Mural Oncology plc (MURA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
251.19%
5-year avg
433.70%
10-year avg
433.70%
Mural Oncology plc’s ROE is less than BioXcel Therapeutics, Inc. (54.12%), greater than Generation Bio Co. (-91.07%), greater than Jasper Therapeutics, Inc. (-121.65%), greater than Evaxion Biotech A/S (-319.99%), less than Verrica Pharmaceuticals Inc. (165.27%), less than BioAtla, Inc. (590.04%), greater than Veru Inc. (-137.24%), less than Liminatus Pharma, Inc. Class A Common Stock (39.18%), greater than Alterity Therapeutics Limited (-48.41%), less than SAB Biotherapeutics, Inc. (33.39%),
| Company | ROE | Market cap |
|---|---|---|
| 54.12% | $45.71M | |
| -91.07% | $35.17M | |
| -121.65% | $30.23M | |
| -319.99% | $33.41M | |
| 165.27% | $79.91M | |
| 590.04% | $49.86M | |
| -137.24% | $35.46M | |
| 39.18% | $25.79M | |
| -48.41% | $31.09M | |
| 33.39% | $36.32M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mural Oncology plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Mural Oncology plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Mural Oncology plc's ROE?
How is the ROE calculated for Mural Oncology plc (MURA)?
What is the highest ROE for Mural Oncology plc (MURA)?
What is the 3-year average ROE for Mural Oncology plc (MURA)?
What is the 5-year average ROE for Mural Oncology plc (MURA)?
How does the current ROE for Mural Oncology plc (MURA) compare to its historical average?